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Abstract 
Overconfidence in false memories is often found in patients with schizophrenia and healthy 
participants with high levels of schizotypy, indicating an impairment of meta-cognition 
within the memory domain. In general, cognitive control is suggested to be modulated by 
natural fluctuations in estrogen. However, whether estrogen exerts beneficial effects on meta-
memory has not yet been investigated. The present study sought to provide evidence that high 
levels of schizotypy are associated with increased false memory rates and overconfidence in 
false memories, and that these processes may be modulated by natural differences in estradiol 
levels. Using the Deese-Roediger-McDermott paradigm, it was found that highly schizotypal 
participants with high estradiol produced significantly fewer false memories than those with 
low estradiol. No such difference was found within the low schizotypy participants. Highly 
schizotypal participants with high estradiol were also less confident in their false memories 
than those with low estradiol; low schizotypy participants with high estradiol were more 
confident. However, these differences only approached significance. These findings suggest 
that the beneficial effect of estradiol on memory and meta-memory observed in healthy 
participants is specific to highly schizotypal individuals and might be related to individual 
differences in baseline dopaminergic activity.  
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1. Introduction 
Schizophrenia is a severe psychiatric disorder characterised by positive symptoms (e.g. 
hallucinations, delusions), negative symptoms (e.g. blunted affect, anhedonia) and cognitive 
deficits (e.g. cognitive disorganisation). While many aspects of cognition are impaired (Green, 
1996; Lesh et al., 2011), it has been purported that memory processes in particular are 
severely affected (e.g. verbal memory: Toulopoulou and Murray, 2004; working memory: 
Manoach et al., 2000; see Aleman et al., 1999, for a meta-analysis).  
Memory impairments in schizophrenia have been linked to delusions (Moritz and 
Woodward, 2006), that is, false beliefs characterised by implausibility, which are fixed in 
spite of evidence to the contrary and asserted with a high degree of confidence (e.g., grandiose 
delusions, persecutory delusions, paranoid delusions). While delusions are a hallmark of the 
diagnosis of schizophrenia, an understanding of their neurocognitive basis is still lacking 
(Gilleen and David, 2005). It has been suggested, though, that delusions are underpinned, at 
least in part, by a general susceptibility to forming false beliefs/memories with a high level of 
confidence (Laws and Bhatt, 2005; Moritz and Woodward, 2006). Therefore, investigating the 
factors influencing confidence in false memories could be of high clinical relevance by 
improving an understanding of the development and maintenance of delusions, and by 
potentially influencing individual treatment options for schizophrenia (Favrod et al., 2014; for 
a review, see Moritz et al., 2014).  
To date, false memories in schizophrenia have received comparatively little attention, 
which might primarily be due to methodological problems. For example, most neurocognitive 
memory assessments measure recall and recognition accuracy by assessing hit rates, but 
neglect false recall and recognition, which can be assessed via false positive error rates 
(Moritz and Woodward, 2006). Those studies that have investigated false memories in 
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schizophrenia have mainly used the Deese-Roediger-McDermott (DRM) paradigm. In this 
paradigm, participants study a series of words (e.g. piano, sound, note, sing, melody, band, 
concert and instrument) that are semantically associated to a non-presented target word (e.g. 
‘music’, the “critical lure”, Roediger and McDermott, 1995). Participants are then required to 
freely recall as many words from the list as possible (recall phase), before being asked to 
complete a forced choice recognition test on a list comprised of previously seen words. The 
recognition list is comprised of the critical lure (strongest association to the study list), new 
words that are related to the study list (strongly associated, but less so than the critical lure), 
and new words that are unrelated to the study list). Typically, healthy participants falsely 
remember seeing the critical lure and / or new-related items (“false-positive response”; 
Roediger et al., 2001), during both the recall and the recognition test. Using this paradigm, it 
has been shown that while patients have poor recall abilities compared to healthy controls 
(increased forgetting, Elvevåg et al., 2004), they do not demonstrate increased false 
recognition (Elvevåg et al., 2004; Moritz et al., 2004). Using the same paradigm, Bhatt et al. 
(2010) found that patients, both with and without delusions, made more false positive 
responses during recognition, compared to controls. Moreover, during free recall, patients 
with delusions produced significantly more false positives than patients without delusions, and 
healthy controls (see also Brébion et al. 1999; Stirling et al., 1997). Thus, the proneness to 
false memories seems to be strongly related to the presence of delusions and a possible reason 
for the inconsistencies in present studies may be that some studies (e.g. Elvevåg et al., 2004; 
Moritz et al., 2004) did not differentiate between patients with and without delusions.  
Considering that generally poorer memory in patients as opposed to healthy controls might 
confound the formation of false memories (Laws and Bhatt, 2005), an alternative avenue for 
research employs a non-clinical model of schizophrenia by investigating healthy participants 
with varying degrees of certain schizotypal personality traits (Ettinger et al., 2014; Johns and 
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van Os, 2001).  Using the DRM paradigm, Laws and Bhatt (2005) investigated false memories 
in healthy participants, grouped according to their scores on the Peters et al. (2004) Delusional 
Inventory (PDI); during recall, high PDI scorers produced significantly more false positives 
compared to low PDI scorers. Saunders et al. (2012) extended these findings to determine 
which aspects of schizotypy are related to false memories by including a multidimensional 
schizotypy measure (The Oxford-Liverpool Inventory of Feelings and Experiences (O-LIFE), 
Mason et al., 2005). The O-LIFE comprises four subscales: Unusual Experiences (i.e. 
perceptual aberrations and odd beliefs), Cognitive Disorganisation (i.e. attentional difficulties 
and thought disorganisation), Introvertive Anhedonia (i.e. blunted affect), and Impulsive Non-
Conformity (i.e. antisocial behaviour). Saunders et al. (2012) found that high scorers on 
Unusual Experiences and/or Cognitive Disorganisation produced more false positives during 
recall compared to low scorers. Consequently, the authors suggest that specific subtypes of 
schizotypy are more susceptible to false memories, and thus might also be more delusion-
prone.  
The investigation of memory processes in schizophrenia and schizotypy has recently 
extended to acknowledge meta-cognitive processes (Bhatt et al., 2010; Moritz et al., 2002; 
2003; 2004; 2005; 2006). Meta-memory refers to an individual’s knowledge and awareness of 
their memory capabilities, and the processes of memory self-monitoring (Nelson and Narens, 
1990; Pannu and Kaszniak, 2005). While many measures of meta-memory have been 
developed (Pannu and Kaszniak, 2005), retrospective confidence ratings are most relevant in 
the context of false memories and delusions. Indeed, Moritz and Woodward (2006) have 
argued that high confidence in false belief is a “defining feature of delusions” (p.185), and that 
the level of confidence one has in a (false) memory determines its impact on overt behaviour. 
That is, one is unlikely to act upon a memory, if one is not confident that it is correct. 
However, high confidence in a false memory could elicit drastic behavioural consequences.  
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 As a meta-cognitive measure of confidence in false memories, Moritz et al. (2004) 
introduced the knowledge corruption index (KCI) defined as the proportion of high 
confidence responses that are errors. Employing the DRM paradigm, these authors found that 
while patients with schizophrenia and controls did not differ in number of false memories per 
se, patients made more high confidence errors both when forgetting items that were presented 
(“misses”) and during false positive recognition.   
With respect to meta-memory processes in healthy participants with schizotypal traits, 
Laws and Bhatt (2005) reported higher KCI scores for false memories in high PDI scorers, 
suggesting they are more confident in their errors than low PDI participants are. Corlett et al. 
(2009) extended these findings by including multiple schizotypy measures. In line with the 
findings of Moritz et al. (2004; 2006), highly schizotypal participants did not produce more 
false positives during recognition than those with low schizotypy. However, a positive 
correlation was found between schizotypy scores and confidence in false positive responses, 
particularly for subscales analogous to positive schizophrenic symptoms (e.g. perceptual 
aberrations, magical ideation). These findings provide further evidence that schizotypy 
provides an appropriate non-clinical model by which to investigate meta-memory impairments 
in schizophrenia.  
A separate stream of research has shown that estrogen can act as a neuroleptic agent 
against the symptoms of schizophrenia (Seeman & Lang, 1990; Häfner, 2003; Riecher-Rössler 
et al., 1994; Kulkarni et al., 2013). Riecher-Rossler et al. (1994) directly investigated the 
possible neuroleptic properties of estradiol by assessing symptomology across the menstrual 
cycle. A significant association was found between levels of estradiol and clinical assessment 
scores; symptoms appeared to improve with increases in estradiol, and deteriorate when 
estradiol levels decreased.  Further research has suggested that memory processes, including 
working memory (Hampson and Morley, 2013), verbal memory (Joffe et al., 2006), implicit 
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memory (Maki et al., 2002), and discriminability (Keenan et al., 2001) can be enhanced with 
increased levels of estrogen (for recent reviews see Duarte-Guterman et al., in press; Frankfurt 
and Luine, in press). However, it is currently unclear whether the effect of estrogen on 
memory occurs because of direct effects of estrogen on memory or rather via hormonal effects 
on memory control functions, such as meta-memory processes (Colzato et al., 2010). Indeed, 
it has been suggested that the enhancing effect of estrogen is particularly evident during tasks 
that demand a high level of (meta-) cognitive control, (Hjelmervik et al., 2012; Jacobs and 
D’Esposito, 2011). Given that meta-memory processes are conceptually comparable to 
cognitive control processes, it follows that meta-memory abilities should be enhanced under 
high estrogen conditions.   
In summary, previous research has suggested that false memories and impaired meta-
memory (indicated by overconfidence in errors) are found both in schizophrenia (potentially 
providing the basis for the experience of delusions in these patients) and in healthy 
participants scoring highly on certain schizotypy traits. Still, studies including measures of 
meta-memory are largely lacking.  Another line of research suggests that within memory 
processes, especially meta-cognitive control functions in memory might be modulated by 
individual differences in estrogen.  
In light of these previous studies, the present study employed a verbal DRM paradigm to 
further investigate whether or not high levels of schizotypy are characterised by increased 
false memory rates (indicated by a high rate of false positive responses during recognition) 
and with impaired meta-memory (as evidenced by high confidence in false memories). In 
addition, we sought to investigate whether false positive recognition rates and meta-memory 
abilities are affected by naturally fluctuating estradiol levels.  
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It was expected that participants with high levels of schizotypy would make more false 
positive errors than low schizotypy scorers and show overconfidence in these false memories, 
especially when their estradiol levels were low.  Further, it was hypothesised that high levels 
of estradiol should have a beneficial effect, especially with respect to meta-cognitive control 
of false memories.  
2. Method 
2.1.Participants 
Seventy-three healthy, normally cycling women (out of 81 tested; see hormone 
assessment section for exclusion details) with a mean age of 23 years (S.D. = 4.86; range: 19 
– 40 years) were assigned to either the high (n = 37) or low estradiol (n = 36) group, based on  
saliva estradiol assays (see section 2.2.3 Hormone assays). This method of classification is 
based on objective quantification of estradiol levels, which are subject to both individual 
(inter-subject) differences and to natural (intra-subject) fluctuations across the menstrual 
cycle. Age did not differ significantly between the groups (t(71) = 1.21, p = 0.23).  
All participants were native English speakers with normal or corrected-to-normal vision. 
Participants did not currently, or in the previous 6 months, use hormonal contraceptives or 
other hormone regulating medications.  
2.2. Procedure and materials 
2.2.1. Schizotypy questionnaire 
The short version of the O-LIFE was used to measure schizotypy (Mason et al., 2005). 
This scale is comprised of four factors: Unusual Experiences, Cognitive Disorganisation, 
Impulsive Non-conformity, and Introvertive Anhedonia. A schizotypy scale with multiple 
subscales was applied as the data reported here form part of a larger battery of cognitive tasks 
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(for each of which different subscales might be most relevant). The Cognitive 
Disorganisation (CD) subscale measures cognitive aspects of schizotypy such as poor 
attention and concentration (Mason et al., 2005). In light of previous research suggesting that 
CD is particularly associated with false memories (e.g. Saunders et al., 2012), this scale is the 
focus of the current study. Moreover, this scale contains items that directly relate to cognitive 
control, such as “Are you easily confused if too much happens at the same time?” and “Do 
you often have difficulties in controlling your own thoughts?”. Given that meta-memory 
processes are essentially cognitive control processes and that estrogen has been shown to 
have an enhancing effect on cognitive control, this subscale was considered most appropriate, 
Participants are required to give yes/no responses, and the score is calculated as the sum of all 
positive answers. A median split was performed based on CD scores (Low CD = 0-4 (M = 
2.39 ± 1.29), High CD = 5-11 (M = 7.11 ± 1.75; see Table 1). 
2.2.2. Verbal meta-memory task 
Six word lists (received and adapted from Moritz et al., (2006) unpublished 
companion study) comprising 12 semantically associated words each were used for the verbal 
meta-memory task. The study lists were associated with the following target words: laugh, 
funeral, road, holiday, time, and panic. The task was completed via a computer using 
MATLAB (R2013a, MathWorks). For the study phase, participants were presented with the 
study list, one immediately following another, in the centre of the screen. Each word from the 
list was presented individually, at a rate of two seconds per word. After all 12 words had been 
presented; participants were given 75 seconds to freely recall as many words from the list as 
possible by writing them down (recall phase). The next list was then presented. This 
procedure was repeated for all six lists. The recognition lists were also made up of 12 words: 
the critical lure, three new words that are related to the study list (“new-related items”), two 
new words that are unrelated to the study list (“new-unrelated items”), and six words from the 
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study list (“old items”). For the recognition phase, participants were presented with the 
recognition list, one word at a time, in a random order, in the centre of the screen. 
Participants were asked to indicate via button press whether they thought the item was old or 
new, and how confident they were in their response on a four-point scale (1-4). Words were 
not randomised between lists, nor was the order of lists, but the order of words within each 
list was randomised. There was no time restriction during the recognition phase. The 
recognition test is the focus of the present paper. From the recognition phase we calculated 
the number of false positive responses, and knowledge corruption indices ([highly confident 
false positives /all highly confident responses] × 100)].  
2.2.3. Hormone assays 
To facilitate collection of a pure saliva sample, women were asked to avoid eating, 
drinking, smoking and brushing teeth for 30 minutes prior to the testing session. One sample 
(2 ml) was collected at the beginning of the test session. The saliva was stored -20°C until 
completion of the study. Samples were then assayed by an independent professional hormone 
laboratory with commercially available hormone assays. Eight women were excluded from 
further analyses due to saliva sample contamination by blood, as indicated by sample 
discolouration and/or extremely high hormone levels out the expected range of the assay.  
Classification of estradiol as high or low was based on a median-split (split score: 3.4 pg/ml). 
Mean estradiol and progesterone levels for each group are given in Table 1. 
  
11	  	  
Table 1. Saliva estradiol and progesterone levels and cognitive disorganisation scores for 
each group (mean±standard deviation).        
 
3. Results 
 
3.1.Salivary hormone concentrations 
Estradiol and progesterone levels did not differ between the high CD and low CD 
subgroups within the low estradiol (LE) (both t(34) < 0.24, n.s.) or high estradiol (HE) group 
(both t(35) < 1.03, n.s.) 
On the other hand, estradiol levels were significantly higher in the HE than in the LE 
subgroup, both within the low CD group (t(36)  = 4.52, p = < 0.001) and the high CD group  
(t(33) = 4.54, p < 0.001). Similarly, progesterone levels were significantly higher in the HE 
than in the LE subgroup both within the low CD group (t(36) = 2.45, p = 0.019) and in the high 
CD group (t(33)  = 2.12, p = 0.041). 
3.2 Data analysis 
2 × 2 ANCOVAs with estradiol (high, low) and cognitive disorganisation (high, low) as 
between-subjects factors were conducted on a variety of measures of memory and meta-
memory (confidence in memory). Because progesterone has been shown to influence 
memory process (Ertman et al., 2011), progesterone levels were included as a covariate. 
  
 
Low cognitive disorganisation High cognitive disorganisation 
 
Low estradiol High estradiol Low estradiol High estradiol 
 
N=15 N=23 N=21 N=14 
Estradiol (pg/ml) 2.11±.82 5.37±2.70 2.04 ±.73 6.58±4.53 
Progesterone (pg/ml) 77.72±77.19 158.67±111.33 76.91±45.18 130.01±101.03 
 
Cognitive 
disorganisation 2.27±1.22 2.48±1.34 7.09±1.7 7.14±1.88 
Age 22.20±4.39 24.21±6.01 22.38±4.66 22.79±3.40 
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3.3. Recognition of critical lure 
3.3.1. False recognition of critical lure 
For the percentage of false-positive responses to the critical lure, the main effects of 
progesterone, CD group, estradiol group as well as the CD × Estradiol interaction did not 
reach significance (all F(1, 68) < 2.09, p ≥ 0.15).  
3.3.2. Knowledge Corruption Index for false recognition of lure items 
The examination of knowledge corruption indices revealed no significant main effects of 
progesterone, CD group, estradiol group, and the CD × Estradiol interaction did not reach 
significance (all F(1,68) < 0.19, p ≥ 0.66).  Table 2 lists false positive error rates and KCIs for 
each group. 
Table 2 False positive error rates and knowledge corruption indices to critical lure items for 
each group (means ± standard error).  
 Low Cognitive Disorganisation High Cognitive Disorganisation 
 Low estradiol 
N = 15 
High estradiol 
N = 23 
Low estradiol 
N = 21 
High estradiol 
N = 14 
False positives  54.44 ± 7.18 56.52 ± 5.21 57.14 ± 6.56  53.57 ± 4.34  
Knowledge corruption 
index 
51.22 ± 8.63 52.61 ± 7.51 58.41 ± 8.65 52.14 ± 9.72  
	  
3.4. Recognition of new-related items 
3.4.1. False recognition of new-related items 
The ANCOVA on the percentage of false-positive responses revealed a significant interaction 
between CD group and Estradiol group, (F(1, 68) = 4.72, p = 0.03, np2 = 0.07). Neither the main 
effects of progesterone, or CD or estradiol group were significant (all F(1, 68) < 1.28, p  ≥ 
0.26.).  
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Post-hoc t-tests (Bonferroni corrected) revealed that the significant interaction was driven by 
a significant difference between the HE and LE groups within the High CD group (t(33) = 
2.48, p = 0.018; see Fig. 1).  
3.4.2. Knowledge Corruption Index for false recognition of new-related items  
 For the knowledge corruption indices for new-related items a significant interaction between 
CD group and E group (F(1, 68) = 5.51, p = 0.02, np2 = 0.08) (see Fig. 2) was found. The 
ANCOVA revealed that the main effects of progesterone, CD, and estradiol group were not 
significant (all F(1, 68) < 0.57, p ≥ 0.45).  
  
Figure. 1. The interactive effect of estradiol and cognitive disorganisation on false 
positive response rates for new-related items (error bars are SEMs * = p < 0.05).  
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Post-hoc t-tests (Bonferroni)  were conducted within each CD group. This revealed that the 
difference between the HE and LE subgroups approached significance, within both the High 
CD (t(33) =  1.57, p = 0.13) and Low CD groups (t(36) = 1.69, p = 0.10) (see Fig. 2). Table 2 
lists false positive error rates and KCIs for each group. 
Table 3 False positive error rates and knowledge corruption indices to new-related items for 
each group (means ± standard error).  
 Low Cognitive Disorganisation High Cognitive Disorganisation 
 Low estradiol 
N = 15 
High estradiol 
N = 23 
Low estradiol 
N = 21 
High estradiol 
N = 14 
False positives  29.63 ± 3.89 31.88 ± 3.24 38.62 ± 4.01 25.00 ± 2.95 
Knowledge corruption  
index 
20.42 ± 3.07 30.64 ± 4.45 32.70 ± 5.32 21.34 ± 3.75 
	  
3.5. Recognition of old items (misses)  
For the percentage of false-negative responses to old items, the main effects of progesterone, 
CD group, estradiol group as well as the CD × Estradiol interaction did not reach significance 
(all F(1, 68) < 1.22, p ≥ 0.27). 
Figure. 2. The interactive effect of  estradiol and cognitive disorganisation  on KCI 
for new-related items (error bars are SEMs; (*) = p < 0.15).  
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The examination of knowledge corruption indices also revealed no significant main effects or 
interactions (all F(1,68) < 0.013, p ≥ 0.72).   
3.6. Relationship between hormones, schizotypy and meta-memory 
The ANCOVA revealed an interactive effect of estradiol and cognitive 
disorganisation on both false memory rates and knowledge corruption for new-related items. 
Therefore, we conducted moderated multiple regression analyses (enter method) to 
investigate any linear relationship between estradiol, progesterone, cognitive disorganisation 
(and estradiol × CD interaction) and both dependent variables, for the new-related items, in 
more detail. To avoid multicolinearity, independent (predictor) variables were centered. The 
CD × E interaction variable was calculated as the product of estradiol and CD (both centered) 
For the false memory rate, the moderated multiple regression model was not 
significant (F(4, 68) = 0.57 p = 0.69). None of the predictors approached significance (all β < 
0.03, p ≥ 0.28).  
Similarly, the moderated multiple regression model for the KCIs was not significant 
(F(4, 68) = 0.46, p = 0.77). None of the predictors approached significance (all β < 0.12, p ≥ 
0.33). 
4. Discussion  
The present study aimed to examine individual differences in false memory rates and 
meta-memory. It was hypothesised that high levels of cognitive disorganisation would be 
associated with increased false memory rates and impaired meta-memory, indicated by 
overconfidence in false memories. Further, the present study sought to investigate whether 
false memories and meta-memory processes are modulated by differences in estradiol levels, 
which occur naturally both between and within participants due to fluctuations across the 
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menstrual cycle. We found that participants with high levels of cognitive disorganisation and 
high estradiol levels produced significantly fewer false memories than highly disorganised 
participants with low estradiol levels. No effect of estradiol was found in participants with 
low levels of cognitive disorganisation. Moreover, highly disorganised participants with high 
levels of estradiol were less confident in their false memories than those with low estradiol. 
In contrast, participants with low levels of cognitive disorganisation and high estradiol levels 
were more confident in their false memories than those with low estradiol levels. These 
findings will be discussed with respect to individual differences in the physiological 
processes underlying memory and meta-memory, including baseline dopaminergic activity. 
Estradiol reduces false recognition in highly schizotypal women. 
Investigating false positive rates for experimentally induced false memories revealed an 
interactive effect of schizotypy and estradiol levels. While increases in estradiol levels did not 
influence false memory rates in participants scoring low on cognitive disorganisation, high 
levels of estradiol were associated with significantly reduced false memory rates in 
participants high in cognitive disorganisation.   
This suggests that estradiol might have a positive effect (reducing false memory rates) 
specifically in participants with high levels of cognitive disorganisation. While the effect of 
estradiol on false memories has not yet been directly examined in humans, recent animal 
studies have demonstrated improved object recognition memory in rats following estradiol 
treatment (e.g. Frye et al., 2007; Inagaki et al., 2010; Jacome et al., 2010). In contrast to 
previous studies investigating recognition performance, the present findings suggest that 
estradiol does not improve false recognition in humans in general. Rather, the effect was 
specific to participants scoring high on cognitive disorganisation. In addition, no such effects 
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were found for false negative error rates, suggesting that the effects of both estradiol and 
schizotypy are specific to false memories.  
 This finding is highly unlikely to be due to higher hormone concentrations in high CD 
participants, as both CD groups (within the high estradiol group) did not significantly differ 
in estradiol (or progesterone) levels. Instead, the present findings suggest that the estradiol 
effect of reducing false memory is specific to individuals with high cognitive disorganisation, 
and thus those especially prone to false memories.  
Estradiol might influence memory via dopaminergic actions  
It has recently been suggested that the effect of estrogen on cognition is dependent on 
individual differences in baseline dopamine function (Colzato and Hommel, 2014). These 
authors suggest that dopaminergic effects on cognitive tasks (including learning and working 
memory) follow an ‘Inverted-U’ function; performance improves with medium dopamine 
levels, but deteriorates with high/low levels. Given that estradiol is associated with higher 
dopamine turnover rates, Colzato and Hommel (2014) speculate that participants with low 
baseline dopamine levels, and thus poor cognitive performance, might benefit from high 
levels of estradiol and concurrent increases in dopamine. In contrast, estradiol would have 
detrimental effects in those with high baseline dopamine levels and good cognitive 
performance, as dopamine increases beyond an optimal point. Indeed, behavioural evidence 
suggests that schizotypy (and schizotypal personality disorder) is associated with aberrant 
dopamine function (e.g. Mohr et al., 2004; McClure et al., 2010). Mohr et al. (2004) 
demonstrated that levodopa (a dopamine agonist) improved visuo-motor performance 
exclusively in participants with high ‘positive’ schizotypy (i.e. magical ideation); low 
schizotypy participants showed a slight performance deterioration with levodopa. 
Subsequently, Mohr et al. (2004) suggest that high schizotypy is associated with a relative 
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hyperdopaminergia, and a better ability to adapt to higher dopamine levels. If high levels of 
cognitive disorganisation are associated with relative hyperdopaminergia, this might also 
explain the improvement in false positive error rates shown by participants high in schizotypy 
with high estradiol levels, while low schizotypy participants showed a slight (non-significant) 
impairment.  
It is notable that the false memory rates seen in the higher schizotypal participants in the 
high estradiol group are comparable to those seen in both the low schizotypy subgroups. This 
might suggest that the effect of estradiol is limited not only to a specific subgroup, but also 
that it is not enhancing per se, rather estradiol has a ‘normalising’ effect on false memory 
rates.  
False recognition of the critical lure is not influenced by estradiol or schizotypy 
The analysis of responses to the critical lures revealed that neither estradiol nor cognitive 
disorganisation affected false positive error rates for the lures. This suggests that false 
memories created by the lure are different to those created by the related items, in that the 
stronger semantic relationship between the critical lure and the word lists might create a 
‘stronger’ false memory trace. In this case, both schizotypy groups might susceptible to a 
ceiling effect; that is, the effect of estradiol might not be strong enough to exert a protective 
effect over false memory rates related to the critical lure. Still, our data suggests that higher 
levels of estradiol might help improve memory processes in those participants high in CD. 
Estradiol reduces false memory confidence in highly schizotypal women 
The analysis of confidence in false memories, measured by KCIs, also revealed a 
significant interaction. In participants scoring high in cognitive disorganisation, high estradiol 
levels resulted in decreased confidence in false memories, while for participants scoring low 
19	  	  
on cognitive disorganisation, confidence in false memories was greater with higher estradiol 
levels. When considering meta-memory as a cognitive control process, the present data 
suggests that the beneficial effect of estradiol on cognitive control (Hjelmervik et al., 2012; 
Jacobs and D’Esposito, 2011; Keenan et al., 2001) might be specific to participants with high 
cognitive disorganisation, at least within the domain of memory. 
Recent evidence suggests that meta-cognitive processes, like memory processes, can be 
influenced by dopamine. Using magnetoencephalography during a forced-choice word 
recognition paradigm, Joensson et al. (2015) demonstrated improved meta-cognitive ability in 
participants who received 100mg of L-dopa, as compared to placebo. In addition, dopamine 
administration was associated with increased activity of the medial prefrontal cortex.  
It is notable that a similar interaction was found for both memory performance, measured 
by the rate of false positives, and meta-memory as measured by KCI. For both measures, 
participants scoring high in cognitive disorganisation benefitted from high levels of estradiol. 
However, this improvement was significant for the false positive error rates only, suggesting 
that the objective measures (false positive error rates) might be more sensitive to the effects 
of schizotypal traits and estradiol levels. This finding supports the notion that the inclusion of 
both objective (e.g. false positive error rates) and subjective measures (e.g. memory 
confidence) is important when investigating memory process across the schizophrenic 
spectrum.  
The relationship between sex hormones, schizotypy and memory processes 
The present study failed to demonstrate a linear relationship between the interactive effect 
of estradiol and schizotypy on either false positive error rates or knowledge corruption. 
However, it is possible that the relationship between these factors it is not linear. Indeed, 
findings from a recent animal study suggest that the enhancing effects of estradiol on 
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recognition abilities are non-linear. Inagaki et al. (2010) demonstrated that medium doses of 
estradiol (17α-estradiol) were most effective, while high and low doses were ineffective. An 
alternative explanation for the lack of a significant relationship is that the observed estrogenic 
effects are not directly related to estradiol but another estrogen, such as estrone. Indeed, 
Louzā et al. (2004) reported that schizophrenic patients given an adjunctive estrone treatment 
showed a trend towards greater symptom improvement than patients given an adjunctive 
placebo. The authors note, however, that this effect was not comparable to the significant 
improvements seen in patients with 17β-estradiol (e.g. Kulkarni et al., 1996; 2001). 
Moreover, given that estradiol is the most potent agonist of estrogen receptors (Turgeon et 
al., 2004), it seems unlikely that estrone is related to the current findings. 
Importantly though, the present results may explain some of the inconsistent findings 
with respect to false memories in schizophrenia, which typically do not control for 
differences in the hormonal environment (e.g. menstrual cycle).  Specifically, if estradiol 
levels are high in patients the risk of false memories might be reduced, as suggested by the 
high CD group of the present study. Thus, differences between patients and controls may 
only be apparent when estradiol levels are low in female patients, or when males dominate 
patient samples. For example, Bhatt et al. (2010) demonstrated elevated false positive 
recognition in both delusional and non-delusional schizophrenic patients compared to 
controls. In this study, both patient groups were male-dominated (12 men 1 woman, and 11 
men, 1 woman respectively). Similarly, using a stem completion task, Stirling et al. (1997) 
report increased rates of false recall in patients compared to controls. This patient sample 
contained 22 males to 5 females. However, using a gender-balanced patient sample (18 
males, 17 females) Moritz et al. (2006) found no excess of false positive error rates in 
patients. Although these studies also vary in task type, these results suggest that, in 
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conjunction with the present study; differing hormonal environments between participants 
may modulate differences between patients and controls (but see Moritz et al., 2004).  
Conclusions  
In conclusion, the present study demonstrated that high levels of estradiol resulted in 
reduced rates of false memories together with a reduction of an over-confidence in these 
memories in participants with high levels of schizotypy, specifically cognitive 
disorganisation. Considering that overconfidence in false memories is key to the development 
and maintenance of delusional symptoms, these results provide additional support for the 
potential role of estrogen as a neuroprotective agent against the symptoms of schizophrenia 
(Seeman and Lang, 1990; Riecher-Rössler et al., 1994; Kulkarni et al., 1996). Moreover, 
these findings lend further support to the notion that estradiol effects are dependent upon 
individual differences in the neurophysiology underlying cognitive processes (e.g. baseline 
dopamine function). For example, a relative hyperdopaminergia (at baseline) in participants 
with high levels of cognitive disorganisation might explain the improvement in false positive 
error rates shown by these participants with high estradiol levels, while low schizotypy 
participants demonstrated a slight impairment. Finally, in the clinical context, the present 
results underline the importance of taking individual differences into account when devising 
tailored treatment options for schizophrenia. 
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